|
|
Registry of Lobbyists - Remy Bouchard
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
Registration Number | Status | | 1540 | Inactive | | Initial registration date | Last date of any changes | 27-April-2017 | 29-September-2020 |
|
Lobbyist's Last Name Bouchard |
Lobbyist's First Name Remy |
Middle Initial |
|
Business Address of Lobbyist 575 Granite Court |
City Pickering |
Province/State ON |
Country CA |
Postal/Zip Code L1W 3W8 |
Telephone 418 456 2013 |
Fax |
|
Business or Firm Name for Lobbyist (if applicable) Purdue Pharma |
Registry of Joint Stock Companies Number |
Business Address of Lobbyist's Business or Firm 575 Granite Court |
City Pickering |
Province/State ON |
Country CA |
Postal/Zip Code L1W 3W8 |
Telephone 418 456 2013 |
Fax |
|
No other beneficiaries of lobbying activities
|
|
|
Description of Employer's Business: Meet with public officials regarding the decision to list and promote company’s products with the goal of reimbursement of the drug by the Province.
Purdue Pharma (Canada) is a research-based pharmaceutical and consumer healthcare company which has operated in Canada for more than 60 years. Its employees are committed to improving the health and quality of life of Canadians. The company has a broad portfolio of prescription and non-prescription medications including: prescription treatments for pain, ADHD, chemotherapy-induced nausea and vomiting (CINV) and various ophthalmic conditions, as well as Consumer Health products. The company supports evidence-based education for the safe use of its products. Privately held and founded by physicians, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma network of companies.
David Pidduck, President&CEO
Howard Gaskin, Senior Director
Remy Bouchard, Manager |
|
|
|
Description |
|
Meet with public officials regarding the decision to list and promote company’s products with the goal of reimbursement of the drug by the Province. |
View
|
|
|
|
No funding from any government or agency
|
No private funding related to lobbying activities
|
|
|
|